Rare Disease R&D Investments Likely To Grow In Biopharma

Spread the love

It wasn’t too long ago that Pfizer’s main areas of interest in R&D were in traditional disease categories: Cardiovascular and Metabolic Disease; Neurosciences; Arthritis and Respiratory Diseases; Anti-infectives; and Oncology. But the Pfizer portfolio is now quite different. While Oncology remains – and is, in fact, the biggest piece […]